Saya Osman

Currently working at MHRA with 3 years of regulatory affairs experience

Knowledge and experience in analysing adverse medicinal product reports. Evaluating type II variation assessments regarding safety updates. Consulting and advising with MAHs Upton caption of cases. Evaluating the benefit risk of signals and developing effective and measurable risk mitigation measures.

Pharmaceutics Masters at UCL